Systemic AAV6-synapsin-GFP administration results in lower liver biodistribution, compared to AAV1&2 and AAV9, with neuronal expression following ultrasound-mediated brain delivery
Abstract Non-surgical gene delivery to the brain can be achieved following intravenous injection of viral vectors coupled with transcranial MRI-guided focused ultrasound (MRIgFUS) to temporarily and locally permeabilize the blood–brain barrier. Vector and promoter selection can provide neuronal expr...
Guardado en:
Autores principales: | Danielle Weber-Adrian, Rikke Hahn Kofoed, Joseph Silburt, Zeinab Noroozian, Kairavi Shah, Alison Burgess, Shawna Rideout, Sebastian Kügler, Kullervo Hynynen, Isabelle Aubert |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4d292ee5b9e644b58491675946f97773 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
AAV vector-mediated in vivo reprogramming into pluripotency
por: Elena Senís, et al.
Publicado: (2018) -
Systemic delivery of shRNA by AAV9 provides highly efficient knockdown of ubiquitously expressed GFP in mouse heart, but not liver.
por: Bryan A Piras, et al.
Publicado: (2013) -
Functional roles of the membrane-associated AAV protein MAAP
por: Lionel Galibert, et al.
Publicado: (2021) -
Pilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques
por: Marie-Laure Arotcarena, et al.
Publicado: (2021) -
In vivo dynamics of AAV-mediated gene delivery to sensory neurons of the trigeminal ganglia
por: Chung H. Dang, et al.
Publicado: (2017)